Protein & Peptide Letters
Title:Letter to the Editor: The Versatility of Tumor Suppressor Proteins and its Therapeutic Potential
Volume: 24 Issue: 8
Author(s): Razvan T. Radulescu*
Affiliation:
- Molecular Concepts Research (MCR), Münster/Westfalen,Germany
Export Options
About this article
Cite this article as:
Radulescu T. Razvan *, Letter to the Editor: The Versatility of Tumor Suppressor Proteins and its Therapeutic Potential, Protein & Peptide Letters 2017; 24 (8) . https://dx.doi.org/10.2174/0929866524666170830124707
DOI https://dx.doi.org/10.2174/0929866524666170830124707 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
22
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Lentiviral Vectors: A Versatile Tool to Fight Cancer
Current Molecular Medicine [General Articles] Perspectives on Cancer Therapy: Cell Cycle Blockers and Perturbators
Current Medicinal Chemistry Lung Cancer: Are we up to the Challenge?
Current Genomics Current Understanding of HSP90 as a Novel Therapeutic Target: An Emerging Approach for the Treatment of Cancer
Current Pharmaceutical Design Targeted Therapies in Solid Tumours: Pinpointing the Tumours Achilles Heel
Current Pharmaceutical Design Editorial: Overview on microRNAs in Cancer Development and Virus Infection
MicroRNA EXTraordinary Bones: Functional and Genetic Analysis of the EXT Gene Family
Current Genomics Homeostasis and the Importance for a Balance Between AKT/mTOR Activity and Intracellular Signaling
Current Medicinal Chemistry C/EBP Transcription Factors in Lung Disease
Current Respiratory Medicine Reviews The Cyclin-Dependent Kinase Inhibitor p21CDKN1A as a Target of Anti-Cancer Drugs
Current Cancer Drug Targets Synthesis, Biological Evaluation and Molecular Dynamics Simulation Studies of Novel Diphenyl Ethers
Medicinal Chemistry Recent Research in Selective Cyclin-Dependent Kinase 4 Inhibitors for Anti-Cancer Treatment
Current Medicinal Chemistry Crosstalk of Long Non-coding RNAs and EMT: Searching the Missing Pieces of an Incomplete Puzzle for Lung Cancer Therapy
Current Cancer Drug Targets Bladder Cancer: Update on Risk Factors, Molecular and Ultrastructural Patterns
Current Medicinal Chemistry Novel Methods of Genetic Modification of Human Pluripotent Stem Cells
Recent Patents on Regenerative Medicine The Role and Predictive Value of Cytokines in Atherosclerosis and Coronary Artery Disease
Current Medicinal Chemistry Von Hippel-Lindau Disease
Current Molecular Medicine Cellular Senescence in the Development and Treatment of Cancer
Current Pharmaceutical Design Threes Company: Regulation of Cell Fate by Statins
Current Drug Targets - Cardiovascular & Hematological Disorders The SCF-type E3 Ubiquitin Ligases as Cancer Targets
Current Cancer Drug Targets